{"transactions":[{"id":2135443,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted stock units","published_at":"2022-10-18T20:17:10.000Z","date":"2022-10-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001439222-22-000091","document":"wf-form4_166612418262958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000091/wf-form4_166612418262958.xml","form_type":"4"}},{"id":2135442,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-10-18T20:17:10.000Z","date":"2022-10-17","kind":"tax_withholding","acquired":false,"shares":1485,"price":27.48,"value":40807.8,"ownership":{"direct":true},"balance_after":8508,"source":{"system":"sec-edgar","filing":"0001439222-22-000091","document":"wf-form4_166612418262958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000091/wf-form4_166612418262958.xml","form_type":"4"}},{"id":2135441,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-10-18T20:17:10.000Z","date":"2022-10-15","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 312 shares purchased through the Company's employee stock purchase plan."}],"balance_after":9993,"source":{"system":"sec-edgar","filing":"0001439222-22-000091","document":"wf-form4_166612418262958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000091/wf-form4_166612418262958.xml","form_type":"4"}},{"id":2353907,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock options (right to buy)","published_at":"2022-03-03T21:09:44.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 1, 2022. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":41000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-03-01","underlying":"Common stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001439222-22-000027","document":"wf-form4_164634176855340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000027/wf-form4_164634176855340.xml","form_type":"4"}},{"id":2353906,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted stock units","published_at":"2022-03-03T21:09:44.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on  March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":11500,"derivative":{"underlying":"Common stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001439222-22-000027","document":"wf-form4_164634176855340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000027/wf-form4_164634176855340.xml","form_type":"4"}},{"id":2378326,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted stock units","published_at":"2022-02-23T21:11:43.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units were granted on  February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units were granted on  February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":658},"source":{"system":"sec-edgar","filing":"0001439222-22-000020","document":"wf-form4_164565067739124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000020/wf-form4_164565067739124.xml","form_type":"4"}},{"id":2378325,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Performance share units","published_at":"2022-02-23T21:11:43.000Z","date":"2022-02-18","kind":"exercise","acquired":false,"shares":1884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested."}],"balance_after":1883,"derivative":{"underlying":"Common stock","underlying_shares":1884},"source":{"system":"sec-edgar","filing":"0001439222-22-000020","document":"wf-form4_164565067739124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000020/wf-form4_164565067739124.xml","form_type":"4"}},{"id":2378324,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:11:43.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":742,"price":29.08,"value":21577.36,"ownership":{"direct":true},"balance_after":4441,"source":{"system":"sec-edgar","filing":"0001439222-22-000020","document":"wf-form4_164565067739124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000020/wf-form4_164565067739124.xml","form_type":"4"}},{"id":2378323,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:11:43.000Z","date":"2022-02-22","kind":"exercise","acquired":true,"shares":658,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5183,"source":{"system":"sec-edgar","filing":"0001439222-22-000020","document":"wf-form4_164565067739124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000020/wf-form4_164565067739124.xml","form_type":"4"}},{"id":2378322,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-23T21:11:43.000Z","date":"2022-02-18","kind":"exercise","acquired":true,"shares":1884,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4525,"source":{"system":"sec-edgar","filing":"0001439222-22-000020","document":"wf-form4_164565067739124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000020/wf-form4_164565067739124.xml","form_type":"4"}},{"id":2391718,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted stock units","published_at":"2022-02-16T22:00:58.000Z","date":"2022-02-14","kind":"exercise","acquired":false,"shares":1738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":1738,"derivative":{"underlying":"Common stock","underlying_shares":1738},"source":{"system":"sec-edgar","filing":"0001439222-22-000010","document":"wf-form4_164504883633702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000010/wf-form4_164504883633702.xml","form_type":"4"}},{"id":2391717,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:00:58.000Z","date":"2022-02-14","kind":"tax_withholding","acquired":false,"shares":590,"price":30.5,"value":17995.0,"ownership":{"direct":true},"balance_after":2641,"source":{"system":"sec-edgar","filing":"0001439222-22-000010","document":"wf-form4_164504883633702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000010/wf-form4_164504883633702.xml","form_type":"4"}},{"id":2391716,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-16T22:00:58.000Z","date":"2022-02-14","kind":"exercise","acquired":true,"shares":1738,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":3231,"source":{"system":"sec-edgar","filing":"0001439222-22-000010","document":"wf-form4_164504883633702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000010/wf-form4_164504883633702.xml","form_type":"4"}},{"id":2397741,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted stock units","published_at":"2022-02-14T21:06:26.000Z","date":"2022-02-10","kind":"exercise","acquired":false,"shares":2068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments."}],"balance_after":4136,"derivative":{"underlying":"Common stock","underlying_shares":2068},"source":{"system":"sec-edgar","filing":"0001439222-22-000003","document":"wf-form4_164487275264401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000003/wf-form4_164487275264401.xml","form_type":"4"}},{"id":2397740,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:06:26.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":725,"price":31.425,"value":22783.125,"ownership":{"direct":true},"balance_after":1493,"source":{"system":"sec-edgar","filing":"0001439222-22-000003","document":"wf-form4_164487275264401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000003/wf-form4_164487275264401.xml","form_type":"4"}},{"id":2397739,"issuer":{"id":4499,"kind":"organization","name":"AGIOS PHARMACEUTICALS, INC."},"owners":[{"id":123022,"kind":"person","name":"Poddar Richa","position":1,"cik":"0001897274","reported_name":"Poddar Richa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2022-02-14T21:06:26.000Z","date":"2022-02-10","kind":"exercise","acquired":true,"shares":2068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."}],"balance_after":2218,"source":{"system":"sec-edgar","filing":"0001439222-22-000003","document":"wf-form4_164487275264401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439222/000143922222000003/wf-form4_164487275264401.xml","form_type":"4"}}]}